{"organizations": [], "uuid": "2fda7285999c1a68fb473ff80d88d0781f93b437", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-announces/brief-novabay-pharmaceuticals-announces-preliminary-sales-for-q4-and-fy17-idUSASB0C00Q", "country": "US", "domain_rank": 408, "title": "BRIEF-Novabay Pharmaceuticals Announces Preliminary Sales For Q4 And FY17", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.146, "site_type": "news", "published": "2018-01-08T19:55:00.000+02:00", "replies_count": 0, "uuid": "2fda7285999c1a68fb473ff80d88d0781f93b437"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novabay-pharmaceuticals-announces/brief-novabay-pharmaceuticals-announces-preliminary-sales-for-q4-and-fy17-idUSASB0C00Q", "ord_in_thread": 0, "title": "BRIEF-Novabay Pharmaceuticals Announces Preliminary Sales For Q4 And FY17", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "novabay pharmaceuticals inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - Novabay Pharmaceuticals Inc:\n* - PRELIMINARY Q4 TOTAL SALES EXPECTED TO SLIGHTLY EXCEED $6 MILLION, UP 49% OVER Q4 OF 2016\n* NOVABAY PHARMACEUTICALS ANNOUNCES PRELIMINARY SALES FOR 2017 FOURTH QUARTER AND FULL YEAR\n* SEES FY 2017 REVENUE ABOUT $18 MILLION * SEES FY 2017 SALES UP 51 PERCENT * FY2017 REVENUE VIEW $17.9 MILLION -- THOMSON REUTERS I/B/E/S\n* Q4 REVENUE VIEW $6.0 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T19:55:00.000+02:00", "crawled": "2018-01-09T17:15:56.010+02:00", "highlightTitle": ""}